Concentrix Corporation $CNXC Stock Holdings Lifted by Invenomic Capital Management LP

Invenomic Capital Management LP boosted its holdings in shares of Concentrix Corporation (NASDAQ:CNXC) by 19.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 822,345 shares of the company’s stock after buying an additional 135,429 shares during the period. Concentrix makes up 1.8% of Invenomic Capital Management LP’s holdings, making the stock its 9th largest position. Invenomic Capital Management LP’s holdings in Concentrix were worth $37,951,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Huntington National Bank grew its stake in shares of Concentrix by 6,011.1% during the third quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after acquiring an additional 541 shares during the last quarter. Quent Capital LLC purchased a new position in shares of Concentrix in the 3rd quarter valued at approximately $29,000. Geneos Wealth Management Inc. raised its position in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the last quarter. Rothschild Investment LLC boosted its stake in Concentrix by 14,980.0% in the 3rd quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock worth $35,000 after purchasing an additional 749 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in Concentrix in the 3rd quarter worth approximately $69,000. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Concentrix

In related news, CEO Christopher A. Caldwell bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, January 29th. The shares were purchased at an average cost of $37.07 per share, with a total value of $37,070.00. Following the completion of the acquisition, the chief executive officer directly owned 362,075 shares in the company, valued at approximately $13,422,120.25. The trade was a 0.28% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.90% of the stock is owned by insiders.

Analyst Ratings Changes

CNXC has been the topic of a number of recent analyst reports. Barrington Research restated an “outperform” rating and set a $62.00 price target on shares of Concentrix in a research note on Monday, January 12th. Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Robert W. Baird set a $52.00 price objective on shares of Concentrix in a report on Wednesday, January 14th. Finally, Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Concentrix has an average rating of “Hold” and an average price target of $63.75.

Concentrix Stock Down 0.2%

CNXC stock opened at $31.67 on Monday. The company has a market capitalization of $1.94 billion, a P/E ratio of -1.52, a price-to-earnings-growth ratio of 0.33 and a beta of 0.50. Concentrix Corporation has a 12 month low of $29.35 and a 12 month high of $66.00. The firm’s fifty day simple moving average is $36.91 and its 200-day simple moving average is $41.37. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40.

Concentrix (NASDAQ:CNXC) last posted its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The company had revenue of $2.55 billion during the quarter, compared to the consensus estimate of $2.54 billion. During the same period in the previous year, the firm posted $3.26 earnings per share. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, equities research analysts forecast that Concentrix Corporation will post 10.11 earnings per share for the current year.

Concentrix Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 10th. Stockholders of record on Friday, January 30th were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 4.5%. The ex-dividend date of this dividend was Friday, January 30th. Concentrix’s payout ratio is -6.91%.

Concentrix Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.